Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 11.9.2024Olikla s.r.o. (OLK)0475DTravoprost Olikla 40 mikrogramov/ml očné roztokové kvapky (int opo 1x2,5 ml (fľ.PP s kvapkadlom))10.9.2024O
 11.9.2024Olikla s.r.o. (OLK)4305EBrimonidin/timolol Olikla 2 mg/ml + 5 mg/ml očné roztokové kvapky (int opo 3x5 ml (fľ.LDPE))10.9.2024U
 11.9.2024Olikla s.r.o. (OLK)5341EPhenylephrine Olikla 100 mg/ml očné roztokové kvapky (int opo 1x5 ml/500 mg (fľ.LDPE))10.9.2024U
 11.9.2024Berlin-Chemie AG (BCE)59166Espumisan L (gte por 1x30 ml (fľ.skl.jantárová))11.9.2024R
 11.9.2024Novartis Slovakia s.r.o. (NVL-2)0601ASANDOSTATIN LAR 30 mg (plv iul 1x30 mg (liek.inj.skl.+1x striek.inj.napl.+nástavec+1x bezp.ihla))12.9.2024O
 11.9.2024Pharmaand GmbH (PNQ)20237Pegasys 180 mikrogramov injekčný roztok v naplnenej injekčnej striekačke (sol inj 1x0,5 ml (striek.inj.skl.napl.+inj.ihla))12.9.2024R
 10.9.2024Reckitt Benckiser (Czech Republic), spol. s r.o. (RKT)2703DStrepfen Sprej Med a Citrón 8,75 mg/ dávka orálna roztoková aerodisperzia (aer ors 1x15 ml (fľ.HDPE))6.9.2024U
 10.9.2024Reckitt Benckiser (Czech Republic), spol. s r.o. (RKT)9675CNurofen 200 mg liečivá náplasť (emp med 2(1x2)x200 mg (vre.PET/LDPE/Al/LDPE))9.8.2024Z
 10.9.2024GE Healthcare Buchler GmbH & Co. KG (GHB-1)51267Sodium Iodide/131 I/ Diagnostic Capsules (cps 5x3,7 MBq (obal polystyrénový))15.11.2024Z
 10.9.2024GE Healthcare Buchler GmbH & Co. KG (GHB-1)51268Sodium Iodide/131 I/ Diagnostic Capsules (cps 5x2,035 MBq (obal polystyrénový))15.11.2024Z
 10.9.2024GE Healthcare Buchler GmbH & Co. KG (GHB-1)51269Sodium Iodide/131 I/ Diagnostic Capsules (cps 5x1,11 MBq (obal polystyrénový))15.11.2024Z
 10.9.2024GE Healthcare Buchler GmbH & Co. KG (GHB-1)51270Sodium Iodide/131 I/ Diagnostic Capsules (cps 5x592 kBq (obal polystyrénový))15.11.2024Z
 10.9.2024GE Healthcare Buchler GmbH & Co. KG (GHB-1)51271Sodium Iodide/131 I/ Diagnostic Capsules (cps 5x333 kBq (obal polystyrénový))15.11.2024Z
 10.9.2024GE Healthcare Buchler GmbH & Co. KG (GHB-1)51272Sodium Iodide/131 I/ Diagnostic Capsules (cps 10x2,035 MBq (obal polystyrénový))15.11.2024Z
 10.9.2024GE Healthcare Buchler GmbH & Co. KG (GHB-1)51273Sodium Iodide/131 I/ Diagnostic Capsules (cps 10x1,11 MBq (obal polystyrénový))15.11.2024Z

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)